| |
| |
|
| Insider
Information: |
Ueno Ryuji |
| Relationship: |
10% Owner |
| City: |
Bethesda |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sucampo Pharmaceuticals, Inc. |
SCMP |
10% Owner |
2015-03-31 |
0 |
2018-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
– – • |
2015-03-31 |
4 |
S |
$14.00 |
$17,450,580 |
I/I |
(1,246,470) |
20,274,689 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
– – • |
2016-12-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
130,760 |
0 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
– – • |
2017-09-11 |
4 |
S |
$12.00 |
$12,000,000 |
I/I |
(1,000,000) |
8,006,585 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
– – • |
2017-12-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
600,000 |
7,406,585 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
– – • |
2018-01-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000,000 |
5,406,585 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
10% Owner |
– – • |
2018-02-13 |
4 |
D |
$18.00 |
$97,318,530 |
I/I |
(5,406,585) |
0 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO & Chief Scientific Officer |
• • • |
2007-12-27 |
5 |
GD |
$0.00 |
$0 |
D/D |
148,529 |
148,530 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO & Chief Scientific Officer |
• • • |
2007-12-27 |
5 |
GD |
$0.00 |
$0 |
I/I |
52,037 |
52,037 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2007-08-02 |
4 |
A |
$0.00 |
$0 |
I/I |
104,074 |
104,074 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2007-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
297,059 |
297,059 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2007-08-29 |
4 |
S |
$10.70 |
$6,015,938 |
I/I |
(562,500) |
1,309,752 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2009-11-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
1,109,752 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2010-08-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
909,752 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2011-11-17 |
5 |
GD |
$0.00 |
$0 |
I/I |
700,000 |
209,752 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-08-30 |
4 |
OE |
$0.00 |
$0 |
I/I |
26,191,050 |
26,400,802 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-10-01 |
4 |
S |
$5.15 |
$198,194 |
I/I |
(38,450) |
26,362,352 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-10-15 |
4 |
S |
$5.86 |
$225,518 |
I/I |
(38,462) |
26,323,890 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-10-31 |
4 |
AS |
$5.13 |
$70,214 |
I/I |
(13,685) |
26,310,205 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-01 |
4 |
AS |
$5.02 |
$119,952 |
I/I |
(23,910) |
26,286,295 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-02 |
4 |
AS |
$5.00 |
$4,339 |
I/I |
(867) |
25,545,501 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-12 |
4 |
AS |
$5.00 |
$18,004 |
I/I |
(3,600) |
26,282,695 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-13 |
4 |
AS |
$5.00 |
$41,825 |
I/I |
(8,362) |
26,274,333 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-14 |
4 |
AS |
$5.01 |
$3,504 |
I/I |
(700) |
26,273,633 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-23 |
4 |
AS |
$5.00 |
$15,007 |
I/I |
(3,000) |
26,270,633 |
0 |
- |
|
| SCMP |
Sucampo Pharmaceuticals, ... |
CEO, Chief Scientific Officer |
• • • |
2012-11-26 |
4 |
AS |
$5.00 |
$32,025 |
I/I |
(6,405) |
26,264,228 |
0 |
- |
|
91 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
